Profile data is unavailable for this security.
About the company
Metropolis Healthcare Limited is an India-based company, which is engaged in providing diagnostic services patients, healthcare providers, and corporates across India and Africa. The Company has a single operating segment, namely Pathology service. It is mainly engaged in the business of running laboratories for carrying out pathological investigations of various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. The Company serves both the business-to-business (B2B) and business-to-customer (B2C) markets. It has approximately 199 clinical laboratories across 22 states in India. Its subsidiaries include Amin's Pathology Laboratory Private Limited, Ekopath Metropolis Lab Services Private Limited, Centralab Healthcare Services Private Limited, Metropolis Histoexpert Digital Services Private Limited, among others.
- Revenue in INR (TTM)12.85bn
- Net income in INR1.48bn
- Incorporated2000
- Employees4.31k
- LocationMetropolis Healthcare Ltd4th Floor, East Wing, Nirlon House,, Dr.MUMBAI 400030IndiaIND
- Phone+91 8 422801801
- Websitehttps://www.metropolisindia.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Yatharth Hospital & Trauma Cre Srvcs Ltd | 7.74bn | 1.29bn | 52.02bn | 2.19k | 39.25 | 5.58 | 30.23 | 6.72 | 15.44 | 15.44 | 92.57 | 108.59 | 0.7952 | 15.71 | 3.58 | 3,542,136.00 | 13.27 | 11.27 | 14.10 | 13.73 | 79.44 | 77.76 | 16.68 | 12.30 | 7.20 | 86.40 | 0.0882 | 0.00 | 28.88 | 45.78 | 74.06 | 95.81 | 3.69 | -- |
| Healthcare Global Enterprises Ltd | 20.39bn | 570.45m | 65.16bn | 6.15k | 115.37 | 7.56 | 26.26 | 3.20 | 4.05 | 4.05 | 145.24 | 61.83 | 0.7435 | 20.91 | 5.92 | 3,316,034.00 | 2.23 | -2.26 | 3.09 | -3.05 | 53.22 | 53.78 | 3.00 | -3.50 | 0.8419 | 1.37 | 0.6324 | -- | 12.80 | 14.35 | 64.08 | -- | -0.3308 | -- |
| Jupiter Life Line Hospitals Ltd | 11.73bn | 1.85bn | 97.71bn | 2.77k | 53.54 | 7.76 | 42.21 | 8.33 | 27.83 | 27.83 | 176.26 | 191.93 | 0.8951 | 9.44 | 20.09 | 4,238,544.00 | 14.12 | -- | 15.75 | -- | 82.00 | -- | 15.78 | -- | 3.15 | 52.16 | 0.00 | -- | 19.83 | -- | 142.25 | -- | -- | -- |
| Metropolis Healthcare Ltd | 12.85bn | 1.48bn | 103.60bn | 4.31k | 70.23 | 8.75 | 41.05 | 8.06 | 28.77 | 28.77 | 249.83 | 231.05 | 0.8185 | 6.72 | 10.00 | 2,979,279.00 | 9.47 | 13.65 | 11.23 | 16.94 | 78.91 | 75.43 | 11.56 | 14.66 | 1.49 | 10.32 | 0.1376 | 23.52 | 5.18 | 9.67 | -10.54 | 1.25 | 21.84 | -- |
| Vijaya Diagnostic Centre Ltd | 6.27bn | 1.33bn | 109.69bn | 2.05k | 82.78 | 15.13 | 55.50 | 17.49 | 12.91 | 12.91 | 61.07 | 70.64 | 0.6114 | 14.83 | 54.30 | 3,054,368.00 | 13.00 | 14.10 | 14.40 | 15.54 | 87.79 | 85.58 | 21.26 | 21.20 | 2.30 | 7.54 | 0.286 | 6.66 | 19.29 | 13.36 | 40.40 | 20.97 | 7.58 | -- |
| Sagility India Ltd | 48.61bn | 2.08bn | 136.93bn | 35.86k | 65.81 | 1.80 | 16.28 | 2.82 | 0.4445 | 0.4445 | 10.38 | 16.25 | 0.4618 | -- | 4.87 | 1,387,054.00 | 1.98 | -- | 2.21 | -- | 99.00 | -- | 4.28 | -- | -- | 2.79 | 0.166 | -- | 12.69 | -- | 58.99 | -- | -- | -- |
| Holder | Shares | % Held |
|---|---|---|
| HDFC Asset Management Co. Ltd. (Invt Mgmt)as of 31 Oct 2024 | 4.84m | 9.45% |
| UTI Asset Management Co. Ltd. (Investment Management)as of 30 Sep 2024 | 2.57m | 5.02% |
| JPMorgan Asset Management (Asia Pacific) Ltd.as of 30 Sep 2024 | 1.73m | 3.37% |
| Franklin Templeton Asset Management (India) Pvt Ltd.as of 31 Oct 2024 | 1.54m | 3.01% |
| Grandeur Peak Global Advisors LLCas of 23 Aug 2023 | 1.45m | 2.83% |
| First Sentier Investors (Singapore)as of 31 Jul 2024 | 1.31m | 2.56% |
| Nippon Life India Asset Management Ltd. (Invt Mgmt)as of 31 Oct 2024 | 1.17m | 2.29% |
| The Vanguard Group, Inc.as of 06 Nov 2024 | 950.47k | 1.86% |
| SBI Life Insurance Co. Ltd. (Investment Portfolio)as of 31 Aug 2024 | 818.55k | 1.60% |
| The Caisse de d�p�t et placement du Qu�becas of 31 Dec 2023 | 808.90k | 1.58% |
